EG18353A - Process for preparing hydroxyacetic acid derivatives for the treatment of diabetic complications - Google Patents

Process for preparing hydroxyacetic acid derivatives for the treatment of diabetic complications

Info

Publication number
EG18353A
EG18353A EG22/87A EG2287A EG18353A EG 18353 A EG18353 A EG 18353A EG 22/87 A EG22/87 A EG 22/87A EG 2287 A EG2287 A EG 2287A EG 18353 A EG18353 A EG 18353A
Authority
EG
Egypt
Prior art keywords
treatment
diabetic complications
acid derivatives
hydroxyacetic acid
preparing
Prior art date
Application number
EG22/87A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG18353A publication Critical patent/EG18353A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EG22/87A 1986-01-17 1987-01-14 Process for preparing hydroxyacetic acid derivatives for the treatment of diabetic complications EG18353A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/000091 WO1987004344A1 (en) 1986-01-17 1986-01-17 Hydroxyacetic acid derivatives for the treatment of diabetic complications

Publications (1)

Publication Number Publication Date
EG18353A true EG18353A (en) 1993-02-28

Family

ID=22195340

Family Applications (1)

Application Number Title Priority Date Filing Date
EG22/87A EG18353A (en) 1986-01-17 1987-01-14 Process for preparing hydroxyacetic acid derivatives for the treatment of diabetic complications

Country Status (26)

Country Link
US (1) US4853410A (da)
EP (1) EP0230379B1 (da)
JP (1) JPS62169775A (da)
KR (1) KR890004104B1 (da)
CN (1) CN1015545B (da)
AT (1) ATE62237T1 (da)
AU (1) AU574001B2 (da)
CA (1) CA1283119C (da)
DD (1) DD266735A5 (da)
DE (1) DE3768966D1 (da)
DK (1) DK21687A (da)
EG (1) EG18353A (da)
ES (1) ES2022319B3 (da)
FI (1) FI94636C (da)
GR (1) GR3001863T3 (da)
HU (1) HU206618B (da)
IE (1) IE59450B1 (da)
IL (1) IL81261A (da)
NO (1) NO171411C (da)
NZ (1) NZ218970A (da)
PH (2) PH22231A (da)
PL (1) PL148082B1 (da)
PT (1) PT84107B (da)
WO (1) WO1987004344A1 (da)
YU (1) YU46042B (da)
ZA (1) ZA87309B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
WO1999043315A1 (fr) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Agent therapeutique utilisable en cas de complication de diabetes
AT502844B1 (de) * 2005-12-12 2007-08-15 Fronius Int Gmbh Schweissbrenner und endstück sowie kontaktrohr für einen schweissbrenner
US20120046356A1 (en) * 2008-10-02 2012-02-23 Cambrex Karlskoga Ab New process for preparing diketones and medicaments
CN105924425B (zh) * 2016-04-29 2018-06-05 浙江师范大学 一种制备二氢硫色满衍生物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359161A (en) * 1963-08-29 1967-12-19 Kefalas As Thiaxanthenols, process of producing and anti-tussive compositions thereof
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4210663A (en) * 1978-11-08 1980-07-01 Pfizer Inc. Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds

Also Published As

Publication number Publication date
PL148082B1 (en) 1989-09-30
DK21687D0 (da) 1987-01-16
JPS62169775A (ja) 1987-07-25
IE59450B1 (en) 1994-02-23
YU46042B (sh) 1992-12-21
FI94636C (fi) 1995-10-10
CN1015545B (zh) 1992-02-19
ZA87309B (da) 1988-07-18
WO1987004344A1 (en) 1987-07-30
NO171411C (no) 1993-03-10
FI873843A (fi) 1987-09-04
HUT48230A (en) 1989-05-29
IL81261A (en) 1992-05-25
CA1283119C (en) 1991-04-16
NZ218970A (en) 1988-11-29
CN87100191A (zh) 1987-09-09
GR3001863T3 (en) 1992-11-23
DK21687A (da) 1987-07-18
NO873854D0 (no) 1987-09-15
AU574001B2 (en) 1988-06-23
EP0230379A2 (en) 1987-07-29
KR870007149A (ko) 1987-08-17
JPH0586952B2 (da) 1993-12-14
DE3768966D1 (de) 1991-05-08
PH24703A (en) 1990-10-01
NO171411B (no) 1992-11-30
AU6764187A (en) 1987-07-30
DD266735A5 (de) 1989-04-12
FI94636B (fi) 1995-06-30
IL81261A0 (en) 1987-08-31
NO873854L (no) 1987-09-15
PL263678A1 (en) 1988-04-14
ES2022319B3 (es) 1991-12-01
KR890004104B1 (ko) 1989-10-20
EP0230379A3 (en) 1988-10-05
YU5787A (en) 1988-04-30
HU206618B (en) 1992-12-28
ATE62237T1 (de) 1991-04-15
PT84107B (pt) 1989-07-31
PT84107A (en) 1987-02-01
US4853410A (en) 1989-08-01
FI873843A0 (fi) 1987-09-04
IE870131L (en) 1987-07-17
EP0230379B1 (en) 1991-04-03
PH22231A (en) 1988-07-01

Similar Documents

Publication Publication Date Title
HUT47949A (en) Process for producing substituted alpha-amino acids, their derivatives and pharmaceuticals comprising these compounds
EG19749A (en) Process for preparing of new chroman and thiochroman derivatives
EP0244364A3 (en) Preparation of olefinic compounds
ES2017498B3 (es) Derivado de 2-fenilbenzoxepina.
GR860205B (en) Method for the preparation of labdan derivatives and their use as medicaments
HUT47955A (en) Process for producing amino acid-1,2-diketo derivatives
PT84108A (en) Process for preparing 7-(substituted) piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline carboxylic acids
EG18353A (en) Process for preparing hydroxyacetic acid derivatives for the treatment of diabetic complications
HU903293D0 (en) Process for producing new chromane derivatives as well as pharmaceutical preparatives containing them
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
DE69015910D1 (de) Pharmazeutische Verwendung von Fettsäuren.
HUT50173A (en) New process for production of indol-3-carbonic acid esthers of derivatives of trans-hexahydro-8-hydroxi-2,6-methan2h-quinolin-3/4h/-on
DE3766921D1 (de) Festes penizillinderivat-hydrat und verfahren zu dessen herstellung.
YU94289A (en) Process for preparing derivatives of 2,1-benzothiazepin-2,2-dioxide-5-carboxylic acids
HUT63600A (en) Process for producing 2r, 3s-malic acid derivatives
HUT50172A (en) Process for production of derivatives of hexahydro-8-hydroxi-2,6-methan-2h-quinoline-3/4h/-on